相关实验视频
Updated: Jun 21, 2025
08:05
Murine Model of Allergen Induced Asthma
Published on: May 14, 2012
40.2K
乔尔基诺利德B减轻了喘小鼠的过敏气道炎症和气道重塑
Haiyan Lin1, Chao Xu2, Jintong Ge3
1Department of Respiratory and Critical Care Medicine, The Affiliated Huai'an No. 1 People's Hospital of Nanjing Medical University, Huai'an, Jiangsu, China.
Allergologia et immunopathologia
|July 6, 2024
概括
乔尔基诺利德B (JB) 通过减少呼吸道炎症和重塑,有效地减少了小鼠的喘症状. 这种天然化合物调节了关键的炎症通路,为喘治疗提供了潜力.
科学领域:
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
- 呼吸系统医学 呼吸系统医学
背景情况:
- 喘是一种常见的慢性呼吸道疾病,导致患者的痛苦和死亡率很高.
- 来自Euphorbia fischeriana的Jolkinolide B (JB) 具有已知的抗炎性质.
- 需要阐明JB在喘进展中的具体作用和机制.
研究的目的:
- 在喘小鼠模型中研究Jolkinolide B (JB) 的治疗潜力.
- 阐明JB发挥抗喘作用的潜在分子机制.
主要方法:
- 卵胺 (OVA) 诱导的小鼠喘模型.
- 使用Jolkinolide B (JB) 的剂量为10mg/kg.
- 评估呼吸道炎症,肺功能和炎症性细胞因子水平 (IL-4,IL-5,IL-13).
- 核因子kappa B (NF-κB) 和转化生长因子-β/Smad3 (TGFβ/smad3) 路径激活的分析.
主要成果:
- 在OVA诱导的喘小鼠中,JB治疗逆转了支气管炎症细胞透和气道壁加厚.
- JB控制的OVA触发的肺功能障碍和肺抵抗.
- 通过降低互白素 (IL) -4,IL-5和IL-13水平,JB减轻了由OVA引起的炎症.
- JB治疗挽救了核因子kappa B (NF-κB) 和转化生长因子-β/Smad3 (TGFβ/smad3) 途径的激活.
结论:
- 乔尔基诺利德B (JB) 在减轻喘小鼠过敏呼吸道炎症和呼吸道改造方面表现出显著的有效性.
- JB通过调节NF-κB和TGFβ/smad3信号通路来发挥其治疗作用.
- 这些发现表明,JB是缓解喘进展的潜在治疗剂.
相关概念视频
01:19Antiasthma Drugs: Leukotriene Modifiers
269
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
269
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
267
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
267
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
245
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
245
01:20Asthma: Pathogenesis and Management
381
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
381
01:26Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
01:20Antiasthma Drugs: Muscarinic Receptor Antagonists
280
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
280